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Abstract
Background: Tuberculous meningitis (TBM) is the most common type of meningitis found in humans and the Human
Immunodeficiency Virus (HIV) is a major risk factor of TBM. This study aimed to identify phenotype differences, such
as clinical manifestations, cerebrospinal fluid (CSF) findings, and chest x-ray results between HIV positive and HIV
negative TBM patients. Methods: This was a comparative analytical study of 123 TBM patients. The patients were
divided into two groups based on their HIV status, and their phenotypes were compared. A retrospective cross sectional
designed study was carried out in case report form using a TBM cohort and Rifampicin dose finding study in the
neurological ward at the Dr. Hasan Sadikin General Hospital Bandung, between January 2015 and August 2016.
Categorical data was analysed using Chi square tests and the alternative Fisher’s Exact test and Mann-Whitney test was
used for numerical data. P-values were significant if p < 0.05. Results: Of the phenotypic parameters, only the CSF
results had statistical difference. HIV positive subjects had higher CSF to blood glucose ratios (0.42 vs. 0.18; p = 0.001)
and fewer leukocyte cells (41 vs. 199; p < 0.001). Conclusions: CSF findings of TBM patients’ revealed differences
between HIV positive and negative patients, whilst clinical manifestations and chest x-ray results showed no
differences.
Keywords: cerebrospinal fluid, chest x-ray, clinical manifestations, HIV, tuberculous meningitis

inflammatory response that occurs in HIV positive and
negative TBM patients, it is hypothesised that there may
be a difference in phenotype profiles such as clinical
manifestations, cerebrospinal fluid findings, and chest
X-ray results. A 2009 study undertaken in Texas, USA
found that there were significant differences between
HIV positive and negative TBM patients, particularly in
relation to higher rates of loss of consciousness amongst
HIV positive patients. However, similar studies undertaken in Vietnam and Spain found that there was no
difference in the level of consciousness amongst HIV
positive and negative TBM patients.8 Furthermore, an
Indian based study reported that the clinical manifestations
and cerebrospinal fluid (CSF) findings in TBM patients
were not significant different between HIV positive and
HIV negative patients.9

Introduction
Meningitis is an inflammation of the meninges; the
membranes that protect the brain and spinal cord. 1
Based on the duration of the inflammatory process,
meningitis can be categorised as acute, subacute, or
chronic. Subacute or chronic meningitis is mostly as a
result of a Mycobacterium tuberculosis infection.1,2
Indonesia has very high prevalence rates of tuberculosis
(TB) when compared to other countries in Asia, sitting
at around 10%.3 The Human Immunodeficiency Virus
(HIV) is a large risk factor in tuberculous meningitis
(TBM) patients.2-4 Findings from a study on meningitis
patients at the Dr. Hasan Sadikin General Hospital
between 2006 and 2008, showed there were a total of
185 patients diagnosed with meningitis and 25% of
those were HIV positive.2

This study aimed to determine whether there were any
differences in the phenotypic profiles amongst HIV
positive and negative TBM patients in Indonesia. The
phenotypic profiles that were focussed on were clinical
manifestations (fever, headache, neck stiffness, paresis,

The decrease in inflammatory reactions due to lower
production of cytokines and inflammatory cells in patients
with HIV play an important role in the pathogenesis of
HIV related TB.5-7 Based on the differences in the
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seizure, loss of consciousness, and other extrapulmonary
tuberculosis), CSF findings (ratios between CSF and blood
glucose, leukocyte cell counts, polymorphonuclear cell
counts, and mononuclear cell counts), and chest X-ray
results (normal, infiltration, cavitation, and miliary). It
is hoped that this research will help improve early
detection of TB meningitis amongst HIV positive and
negative patients so that time specific treatment may be
carried out.

Methods
This was a comparative analytical study that utilised
data from a previous cross-sectional retrospective study
of TBM patients who participated in the Rifampicin
Dose Finding Study at the Neurology Department of the
Dr. Hasan Sadikin General Hospital between January
2015 and August 2016. All participants of the study
were TBM patients who had completed their TB
treatment at the Neurology Department of the Dr. Hasan
Sadikin General Hospital and total sampling methods
were performed. The selection criteria of this study
included all adult inpatients (aged ≥ 18 years old) from
the Neurology Department of the Dr. Hasan Sadikin
General Hospital. Participants had been diagnosed with
TBM by definite diagnosis, probable diagnosis, or
possible diagnosis (Table 1)10, had HIV test results, a

record of the clinical manifestations of meningitis, CSF
findings, and chest X-ray results in their case report
form (CRF). The exclusion criterion was incomplete
CRF data.The variables noted in this study were the
TBM patient's HIV status, age, gender, previous TB
treatments, history of pulmonary TB, duration of illness,
the clinical manifestations (temperature of ≥ 38.3 °C,
headache, stiffness of the neck, paresis, cranial nerve
palsy, seizures, loss of consciousness, extrapulmonary
TB in addition to TBM), diagnosis of TBM (Table 1) 10,
stage of TBM according to the Medical Research
Council of Great Britain (Table 2)11, CSF profiles (CSF
and blood glucose ratio, the number of leukocytes,
polymorphonuclear cells, and mononuclear cells), and
chest X-ray results (normal, infiltration, cavitation, or
miliary).
Data was presented in the form of proportion (%),
median, and interquartile ranges. Chi squared tests
were used for categorical data analysis with the
alternative of Fisher's exact test. Mann-Whitney tests
were used for numerical data analysis because the
data distribution was not considered normal. P-values
were significant if p < 0.05. This study received
ethical approval from the Research Ethics Committee of
the Dr. Hasan Sadikin General Hospital, Bandung,
Number: 66/UN6.C1.3.2/KEPK/PN/2016.

Table 1 TBM Diagnosis10

Diagnosis

Criteria

Definite TBM
Probable TBM

Clinical meningitis (nuchal rigidity and abnormal CSF parameters) and acid-fast bacilli in
CSF
Clinical meningitis and ≥ 1 of the following:
1) Acid fast bacilli found in any sample other than from the CSF
2) Suspect active pulmonary TB on the basis of chest X-ray
3) Clinical evidence of the other extrapulmonary TB

Possible TBM

Clinical meningitis an at least 4 of the following: history of TB, duration of illness > 5
days, focal neurological signs, altered consciousness, yellow CSF, predominance of
lymphocytes in the CSF, CSF: blood glucose ratio < 0.5

Notes: TBM, Tuberculous meningitis

Table 2. British Medical Research Council Clinical Criteria for Severity of TBM 11

Stage/grade

Classic criteria

I

Fully conscious and no focal deficits

II

Conscious but with inattention, confusion, lethargy, and focal neurological signs

III

Stupor or coma, multiple cranial nerve palsies, or complete hemiparesis or paralysis

Notes: TBM, Tuberculous meningitis
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Results
During the selected study period there were 176 adult
patients diagnosed with meningitis (Figure 1). A total of
26 patients were excluded from the study as a result of
cryptococcal meningitis (n = 10), bacterial meningitis
(n = 8), or viral meningitis diagnoses (n = 8) leaving 150
patients with a TBM diagnosis. A further 27 patients were
excluded from the study due to incomplete records,
including no CSF findings (n = 3), no HIV test results (n
= 10), chest X-ray results (n = 3), or incomplete date
regarding their clinical manifestations on their CRF (n =
11). The remaining 123 patients, comprising of 20
(16.26%) HIV positive patients and 103 (83.74%) HIV
negative patients were analysed.
The general characteristics of TBM (Table 3) showed
significant differences between HIV positive and HIV
negative patients, except for age (p = 0.488) and a
history of pulmonary TB (p = 0.443). The majority of
subjects were male, with a median age of 33 years in the
HIV positive group and 31 years in the HIV negative
group. Previous TB treatment in the TBM patients was
more common in the HIV positive group compared to
the HIV negative group (p = 0.026). The duration of
illness in TBM patients who were HIV positive was
longer than the HIV negative group (p = 0.006).

77

The clinical manifestations and stages of TBM in patients
did not have significant differences between the HIV
positive and negative groups (Table 3). Clinical manifestations such as fever (20.39%), headache (91.26%), neck
stiffness (90.29%), and paresis (56.31%) were more
common in the HIV negative group. Conversely, clinical
manifestations such as cranial nerve palsy (85%) and
extrapulmonary TB (20%) were more common in the
HIV positive group. There were 18 TBM patients with
extrapulmonary TB (11.38%), such as miliary TB (n =
3), spondylitis TB (n = 3), abdominal TB (n = 2), and
lymphadenitis TB (n = 10). The percentage of TBM
patients with a definitive diagnosis was higher in the HIV
negative group (34.95%), whereas a possible diagnosis
of TBM was more common in the HIV positive group
(25%). Most TBM patients only had a probable
diagnosis (61.79%) and had stage II TBM (76.42%).
Based on the Mann-Whitney tests, there were significant differences in the CSF to blood glucose ratio and
CSF leukocyte cell counts amongst the HIV positive
and negative groups. The results of the CSF findings
(Table 4) showed the ratio of glucose in the CSF and
blood was higher in the HIV positive group (p = 0.001),
however the number of leukocytes in the HIV positive
group was lower (p < 0.001). Chest X-ray results (Table
4) did not show any significant differences between the

176 adult patients diagnosed with meningitis from CRF data
in period of January 2015–August 2016
- 10 patients diagnosed with cryptococcal meningitis
- 8 patients diagnosed with bacterial meningitis
- 8 patients diagnosed with viral meningitis
150 adult patients diagnosed with TBM
-

CSF analysis was not performed in 3 patients
HIV test was not performed in 10 patients
Chest X-ray was not performed in 3 patients
11 clinical manifestations data from CRF was incomplete
123 adult patients diagnosed with TBM

20 patients with HIV-infected

103 patients without HIV-infected

Figure 1. Flow of Patients Who Included in the Study
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Table 3. General Characteristics, Clinical Manifestations, Diagnosis, and Stage of TBM Patients amongst HIV
Positive and HIV Negative Patients

Characteristics

HIV positive
(n = 20)

HIV negative
(n = 103)

General Characteristics
Age (years), median (IQR)
33 (26-41)
Gender, n (%)*
Men
16 (80)
Women
4 (20)
Previous TB treatment, n (%)*
9 (45)
History of pulmonary TB, n (%)
9 (45)
Duration of illness (days), median (IQR)*
90 (28-120)
Clinical Manifestations
Fever (temperature ≥ 38.3°C), n (%)
4 (20)
Headache, n (%)
18 (90)
Neck stiffness, n (%)
18 (90)
Hemiparesis, n (%)
8 (40)
Paraparesis, n (%)
2 (10)
Seizures, n (%)
3 (15)
Cranial nerve palsy, n (%)
17 (85)
Loss of consciousness, n (%)
GCS 12–14
10 (50)
GCS ≤11
6 (30)
Extrapulmonary TB in addition to TBM, n (%)
4 (20)
TBM Diagnosis*
Definitive diagnosis, n (%)
2 (10)
Probable diagnosis, n (%)
13 (65)
Possible diagnosis, n (%)
5 (25)
TBM Stage
Stage I, n (%)
0 (0)
Stage II, n (%)
15 (75)
Stage III, n (%)
5 (25)

31 (24-39)
55 (53.4)
48 (46.6)
22 (21.36)
37 (35.92)
30 (14-45)

p
0.488
0.028
0.026
0.443
0.006

21 (20.39)
94 (91.26)
93 (90.29)
42 (40.78)
16 (15.53)
11 (10.68)
71 (68.93)

0.968
0.856
0.968
0.948
0.735
0.699
0.145

57 (55.34)
24 (23.3)
14 (13.59)

0.661
0.572
0.491

36 (34.95)
63 (61.17)
4 (3.88)

0.001

5 (4.85)
79 (76.7)
19 (18.45)

0.51

Notes: n, number of patients; proportions (%), number of patients/number of available data;
IQR, interquartile range; GCS, Glasgow Coma Scale; TB, tuberculosis;
HIV, human immunodeficiency virus; TBM stadium based on Medical Research Council of Great Britain.
*p < 0.05
**Age and duration of illness were analysed by Mann-Whitney test
Gender, previous TB treatment, hemiparesis, and cranial nerve palsy were analysed by Chi squared test
Table 4. CSF Findings and Chest X-ray Results between HIV Positive and HIV Negative TBM Patients

Characteristics
CSF findings
Ratio of CSF:blood glucose, median (IQR)*
Leukocytes (cells counts/mL), median (IQR)*
% PMN, median (IQR)
% MN, median (IQR)
Chest X-Ray results
Normal, n (%)
Abnormal, n (%)
Infiltration, n (%)
Cavitation, n (%)
Miliary, n (%)
Others, n (%)

HIV positive
(n = 20)

HIV negative
(n = 103)

p

0.42 (0.33-0.47)
41 (3-99)
22.5 (0.75-76.75)
77.5 (23.25-99.25)

0.18 (0.11-0.34)
199 (57.5-404)
39 (20-63)
61 (36-80)

0.001
<0.001
0.325
0.327

6 (30)
14 (70)
11 (55)
0 (0)
3 (15)
1 (5)

26 (25.24)
77 (74.76)
49 (47.57)
9 (8.74)
23 (22.22)
20 (19.42)

0.657
0.543
0.353
0.563
0.192

Notes: n, number of patients; proportions (%), number of patients/number of available data;
IQR, interquartile range; CSF, cerebrospinal fluid; MN, mononuclear;
PMN, polymorphonuclear; HIV, human immunodeficiency virus
*p-value <0.05
**CSF findings were analysed by Mann-Whitney test
Chest X-Ray results were analysed by Fisher’s exact test
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HIV positive and negative groups (p = 0.657). Infiltrates (48.78%) were the most common abnormality
found in the chest X-rays of the subjects.

Discussion
In the present study, TBM (86.39%) was the most
common type of meningitis followed by cryptococcal
meningitis (5.68%), viral meningitis (4.55%), and
bacterial meningitis (4.55%). These results were in
accordance with a study conducted in South Africa in
2009, which found that meningitis was mostly caused by
M. tuberculosis infections (56.87%).12-14 Furthermore,
males made up a larger proportion of the present study’s
population (57.72%), findings that are similar to studies
carried out in Vietnam, which reported higher TBM
rates in male patients (60.79%), with 88.5% of them
being HIV positive. Additionally, studies carried out in
South Africa, Europe, and Argentina have all reported
higher percentages of male patients with TBM.10,12,15
Results from the present study suggest that HIV positive
patients with TBM experienced a longer duration of
illness. The duration of illness is defined as the time
from the first clinical manifestations of meningitis until
the patient presents at the hospital. In patients with HIV,
activation of the inflammatory response occurs for a
longer period however the inflammatory reaction is
decreased, this results in many patients seeking
treatment later than HIV negative patients.5-7 In the
present study, leukocyte cell counts of the CSF in HIV
positive TBM patients were less than the HIV negative
group. As such, patients who are HIV positive are more
likely to present to hospital when their TBM had
entered the advance stages because the initial clinical
symptoms may not have been obvious.1,16
There were 11 HIV positive TBM patients (55%) who
had never had TB treatment, whilst the others had a
history of previous TB treatment. Previous treatment for
TB was more common in the HIV positive group
compared to the HIV negative group, as such patients
who are HIV positive have a higher risk of relapse.4
Furthermore, a higher percentage of TBM patients had a
history of pulmonary TB in the HIV positive group
(45%) compared to the HIV negative group (35.92%).
These findings are in contrast with a Vietnamese study,
which suggests there were no significant differences in
previous TB treatments in HIV positive and negative
TBM patients.10
HIV infections did not appear to affect the patient's
clinical manifestations of TBM. These findings are in
line with similar studies conducted in Vietnam, India,
and Brazil. The clinical manifestations of TBM patients
in Vietnam, such as fever, cranial nerve palsy, and stage
of TBM in HIV positive patients were not significantly
different to the HIV negative group.10 Additionally in
Makara J. Health Res.
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India, clinical manifestations such as headache, cranial
nerve involvement, and endocrine dysfunction in TBM
patients did not show any significant differences between
the HIV positive and HIV negative groups.12 Furthermore,
a Brazilian study reported that the clinical presentation
of HIV positive TBM patients were not specific.17 In the
present study, results from chest X-rays of the TBM
patients were not significantly different between the two
groups. These results are similar to a 2003 Vietnamese
study, in which chest X-ray results of HIV positive and
negative TBM patients showed no differences.10
There was a total of 16.26% of TBM patients who were
HIV positive in the current study. A definite diagnosis
of TBM was more common in the HIV negative group
(34.95%), whilst a diagnosis of possible TBM was more
common in the HIV positive group (25%). The majority
of participants had a probable diagnosis of TBM (61.79%).
These findings differ to those from the Vietnamese
study, that found there was no significant difference
between the diagnoses (definitive, probable, or possible)
of HIV positive and negative TBM patients .10 Furthermore, a study in South Africa showed a high prevalence
of HIV positive TBM patients (88.3%) and reported
different results. Most HIV positive TBM patients were
diagnosed with a definitive diagnosis (44.34%) compared
to a probable diagnosis (20.01%) and a possible diagnosis
(35.65%).12 It could be concluded that HIV prevalence
may affect the type of diagnosis used for TBM patients.
Other factors that may influence the diagnosis is clinical
settings with limited resources.13,18 TBM can be difficult to
diagnose and might be based only on clinical presentations
and preliminary CSF findings, without definitive microbiologic confirmation.19-21 Diagnostic imaging such as
computed tomography or magnetic resonance imaging
may also be used to diagnose TBM patients, however it is
not widely available in some countries.2,13 In the present
study, computed tomography scanning was rarely
available and decisions to perform lumbar punctures
were based on clinical signs only. As such, only 31% of
TBM patients were given a definitive diagnosis.
The majority of patients in the study were categorised as
second stage TBM, however the stage of TBM between
HIV positive and HIV negative patients did not show
any statistical differences. These findings were again
similar to those of a Vietnamese study that also showed
there was no significant differences between the stages of
TBM in HIV positive and negative patients.10 Results
from an Indian study showed that there were no
differences in the CSF findings of TBM HIV positive
and negative patients, whereas results of the present
showed a significant difference.22
Additionally, results from the present study showed that
leukocyte cell counts of HIV positive TBM patients were
lower, and the ratio between the glucose in the CSF and
the glucose in the blood was higher. Furthermore, CSF
December 2017 | Vol. 21 | No. 3
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analysis in TBM patients revealed there was an increase
in lymphocytes with other inflammatory cells.23,24 This
is in contrast to the Vietnamese study, which found that
TBM patients had a high CSF cell count, with neutrophil
predominance. A low percentage of CSF lymphocytes
were an abnormality that was found to be associated
with death. Patients with advanced HIV usually had a
low number of lymphocytes in the peripheral blood,
which may be reflected in the low CSF lymphocyte
count. Furthermore, TBM may stimulate increased HIV
replication in the CNS compartment, thus resulting in
the destruction of CSF lymphocytes.25-27
M. tuberculosis infections can lead to an increase of
glucose consumption by inflammatory cells and changes
in glucose transport from blood to the CSF, resulting in
a decrease of the CSF to blood glucose ratio, which was
<0.5.2,28 In HIV positive patients, the inflammatory
reaction was decreased due to a lower production of
certain cytokines, such as Interferon-gamma, Tumour
Necrosis Factor-alpha, and Interleukin. Cytokines play an
important role in the pathogenesis of HIV related TBM.
Inflammatory reactions, which are decreased in HIV
positive individuals, could cause a decrease in inflammatory cells, thus there is less glucose consumption by
inflammatory cells. Therefore, the ratio between CSF and
blood glucose was higher in HIV positive patients.5-7,28
The present study has several limitations. Firstly, this
was a cross-sectional retrospective study and as such
there was some incomplete data on the CRFs, such as
clinical manifestations (7.3%), HIV test results (6.7%),
chest X-ray results (2%), and CSF findings (2%).
Incomplete data regarding clinical manifestations may
have influenced the results in this study as there were no
significant differences between HIV positive and HIV
negative patients, whereas similar studies did show
significant differences. Secondly, a definitive diagnosis
of TBM is difficult to establish, with only 31% of TBM
patients having a definitive diagnosis in the present
study. Lastly, we were only able to include patients in a
single (large) hospital.

Conclusions
There were, significant differences in the CSF findings
of HIV positive and negative TBM patients, whilst there
were no significant differences in the clinical manifestations and chest X-ray results. HIV positive subjects
had a higher CSF to blood glucose ratio and fewer
leukocyte cells. As such, it is our recommendation that
TBM patients, who have a higher CSF to blood glucose
ratio and fewer leukocytes on CSF analysis, should be
investigated for a possible HIV infection.
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